Susquehanna Fundamental Investments’s ChemoCentryx, Inc. CCXI Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$336K	Buy	+13,400	New	+$377K	0.01%	1217

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Susquehanna Fundamental Investments's CCXI Position: Q1 2022 in Review

Susquehanna Fundamental Investments opened a new position in ChemoCentryx, Inc. (CCXI) in Q1 2022: 13,400 shares worth $336K. The stake represents 0.01% of the portfolio and ranks #1217 among its holdings.

176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

Susquehanna Fundamental Investments held 13,400 shares of ChemoCentryx, Inc. worth $336K as of Q1 2022.
ChemoCentryx, Inc. was a new Susquehanna Fundamental Investments position in Q1 2022.
ChemoCentryx, Inc. made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1217 holding.
176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.